Nine of the largest pharma companies ink deals with Trump to lower drug prices
U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White House December 19, 2025 in
Read More
Pharmaceuticals
UnitedHealth Group commits to improvements after independent audit, patient backlash
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth
Read More
Trump signs executive order reclassifying cannabis, opening door to broader weed access
U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C.,
Read More
Stocks making the biggest moves midday: Dell, Arrowhead Pharmaceuticals, Urban Outfitters &
Check out the companies making the biggest moves midday: Arrowhead Pharmaceuticals — The stock popped 19% after the biopharmaceutical company
Read More
Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov.
Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in
Read More
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on
Read More
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing
A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish
Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1
Read More
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and
Eli Lilly and Nvidia are partnering to build what they call the pharmaceutical industry’s “most powerful” supercomputer and so-called AI
Read More